These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24614081)

  • 1. COX-2 drives metastatic breast cells from brain lesions into the cerebrospinal fluid and systemic circulation.
    Allen JE; Patel AS; Prabhu VV; Dicker DT; Sheehan JM; Glantz MJ; El-Deiry WS
    Cancer Res; 2014 May; 74(9):2385-90. PubMed ID: 24614081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
    Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
    Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis.
    Magbanua MJ; Melisko M; Roy R; Sosa EV; Hauranieh L; Kablanian A; Eisenbud LE; Ryazantsev A; Au A; Scott JH; Park JW
    Cancer Res; 2013 Dec; 73(23):7134-43. PubMed ID: 24142343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B.
    Lin WL; Lee YJ; Wang SM; Huang PY; Tseng TH
    Eur J Pharmacol; 2012 Apr; 680(1-3):8-15. PubMed ID: 22329896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer.
    Barnes NL; Warnberg F; Farnie G; White D; Jiang W; Anderson E; Bundred NJ
    Br J Cancer; 2007 Feb; 96(4):575-82. PubMed ID: 17285134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells.
    Basu GD; Liang WS; Stephan DA; Wegener LT; Conley CR; Pockaj BA; Mukherjee P
    Breast Cancer Res; 2006; 8(6):R69. PubMed ID: 17156488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
    Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer.
    Singh B; Berry JA; Vincent LE; Lucci A
    J Surg Res; 2006 Jul; 134(1):44-51. PubMed ID: 16678856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen estimation in cerebrospinal fluid in patients with metastatic breast cancer.
    Dearnaley DP; Patel S; Powles TJ; Coombes RC
    Oncodev Biol Med; 1981; 2(4):305-11. PubMed ID: 7301610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models.
    Zhao H; Cui K; Nie F; Wang L; Brandl MB; Jin G; Li F; Mao Y; Xue Z; Rodriguez A; Chang J; Wong ST
    Breast Cancer Res Treat; 2012 Jan; 131(2):425-36. PubMed ID: 21394501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
    Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L
    Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
    Tortora G; Caputo R; Damiano V; Melisi D; Bianco R; Fontanini G; Veneziani BM; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2003 Apr; 9(4):1566-72. PubMed ID: 12684433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib antagonizes the cytotoxic effect of cisplatin in human gastric cancer cells by decreasing intracellular cisplatin accumulation.
    Chen M; Yu L; Gu C; Zhong D; Wu S; Liu S
    Cancer Lett; 2013 Feb; 329(2):189-96. PubMed ID: 23142285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases.
    Patel AS; Allen JE; Dicker DT; Peters KL; Sheehan JM; Glantz MJ; El-Deiry WS
    Oncotarget; 2011 Oct; 2(10):752-60. PubMed ID: 21987585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer.
    Melisi D; Caputo R; Damiano V; Bianco R; Veneziani BM; Bianco AR; De Placido S; Ciardiello F; Tortora G
    Endocr Relat Cancer; 2005 Dec; 12(4):1051-8. PubMed ID: 16322342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytic IGFBP2 and CHI3L1 in cerebrospinal fluid drive cortical metastasis of HER2+breast cancer.
    Ansari KI; Bhan A; Liu X; Chen MY; Jandial R
    Clin Exp Metastasis; 2020 Jun; 37(3):401-412. PubMed ID: 32279122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.
    Palmieri D; Bronder JL; Herring JM; Yoneda T; Weil RJ; Stark AM; Kurek R; Vega-Valle E; Feigenbaum L; Halverson D; Vortmeyer AO; Steinberg SM; Aldape K; Steeg PS
    Cancer Res; 2007 May; 67(9):4190-8. PubMed ID: 17483330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer.
    Backhus LM; Sievers E; Lin GY; Castanos R; Bart RD; Starnes VA; Bremner RM
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):297-303. PubMed ID: 16872953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
    Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
    Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.